Skip to main content
Caplight Logo









Hippo Scribe

Hippo Scribe

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://gethipposcribe.com

Last Round

Accelerator

Apr 5, 2023

Total Funding Raised

$500,000

Company Overview

Hippo Scribe operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Accelerator round in April 2023.

Hippo Scribe is a healthcare technology company that provides an AI-powered clinical documentation assistant designed to automate note-taking for physical therapists, occupational therapists, and speech-language pathologists.

Sector

Healthcare & Life Sciences

Verticals

NLP & Conversational AI, Medical AI, Vertical SaaS, Document Management, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Hippo Scribe Comparables

Compare Hippo Scribe with similar companies based on industry and business-model similarity.

Hippo Scribe comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Comprehend Health
88%
SPRY Therapeutics, Inc.
85%
DeepCura
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Hippo Scribe Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 5, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Hippo Scribe Investors

Notable investors and investment history

Hippo Scribe investors
InvestorRounds
Y CombinatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 32% MoM, reaching 3K.

  • May 3, 2025

    Monthly visitors grew 93% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Hippo Scribe Filings

Explore SEC and related filing metadata, where available.

Hippo Scribe filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Hippo Scribe's valuation, stock price, and market status.

Is Hippo Scribe a public or private company?

Hippo Scribe is a private company.

What is the current stock price of Hippo Scribe?

Hippo Scribe is a private company, so its shares have no public market price. Caplight tracks Hippo Scribe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hippo Scribe worth (valuation)?

Valuation information for Hippo Scribe is not publicly available.

Can I buy Hippo Scribe stock?

Hippo Scribe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hippo Scribe's last funding round?

Hippo Scribe's most recent funding round was Accelerator on April 5, 2023.

Who are the main investors in Hippo Scribe?

Key investors in Hippo Scribe include Y Combinator.

Will Hippo Scribe IPO soon?

No public IPO plans have been announced for Hippo Scribe.

How can I track Hippo Scribe secondary market activity?

Caplight tracks bids, offers, and trades in Hippo Scribe's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range2
Year Founded2023
Last FundingApr 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?